Skip to main content
Livermore
Livermore
ZHEN

Macquarie Group Ltd

SEC CIK
0001418333
Latest filing
Aug 14, 2026

TEVA holding history

Teva Pharmaceutical Industries Ltd in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings

Shares (Q2 2026)
56,337
Value
$1.91M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TEVA by Macquarie Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202656,337$1.91M<0.1%+5,998+11.9%AddedHolders
Q1 202650,339$1.52M<0.1%+12,527+33.1%AddedHolders
Q4 202537,812$1.18M<0.1%−14,741−28.0%ReducedHolders
Q3 202552,553$1.06M<0.1%+5,924+12.7%AddedHolders
Q2 202546,629$781.5K<0.1%00.0%UnchangedHolders
Q1 202546,629$716.7K<0.1%−3,450−6.9%ReducedHolders
Q4 202450,079$1.10M<0.1%+4,415+9.7%AddedHolders
Q3 202445,664$822.9K<0.1%+2,330+5.4%AddedHolders
Q2 202443,334$703.8K<0.1%−741−1.7%ReducedHolders
Q1 202444,075$621.9K<0.1%+9,942+29.1%AddedHolders
Q4 202334,133$356.6K<0.1%+786+2.4%AddedHolders
Q3 202333,347$340.1K<0.1%−4,596−12.1%ReducedHolders
Q2 202337,943$285.7K<0.1%−5,197−12.0%ReducedHolders
Q1 202343,140$381.8K<0.1%00.0%UnchangedHolders
Q4 202243,140$393.4K<0.1%+6,483+17.7%AddedHolders
Q3 202236,657$296.0K<0.1%−210−0.6%ReducedHolders
Q2 202236,867$278.0K<0.1%−8,243−18.3%ReducedHolders
Q1 202245,110$424.0K<0.1%00.0%UnchangedHolders
Q4 202145,110$361.0K<0.1%−55,760−55.3%ReducedHolders
Q3 2021100,870$982.0K<0.1%+8,879+9.7%AddedHolders
Q2 202191,991$910.0K<0.1%−15,463−14.4%ReducedHolders
Q1 2021107,454$1.24M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.